Sonoma Pharmaceuticals (SNOA) Short Interest Ratio & Short Volume $2.39 -0.03 (-1.24%) Closing price 02/21/2025 03:46 PM EasternExtended Trading$2.37 -0.02 (-0.84%) As of 02/21/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Sonoma Pharmaceuticals Short Interest DataSonoma Pharmaceuticals (SNOA) has a short interest of 41,500 shares, representing 2.61% of the float (the number of shares available for trading by the public). This marks a 75.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 50,978 shares to cover all short positions.Current Short Interest41,500 sharesPrevious Short Interest23,700 sharesChange Vs. Previous Month+75.11%Dollar Volume Sold Short$111,635.00Short Interest Ratio0.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares1,620,000 sharesFloat Size1,590,000 sharesShort Percent of Float2.61%Today's Trading Volume39,279 sharesAverage Trading Volume50,978 sharesToday's Volume Vs. Average77% Short Selling Sonoma Pharmaceuticals? Sign up to receive the latest short interest report for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNOA Short Interest Over TimeSNOA Days to Cover Over TimeSNOA Percentage of Float Shorted Over Time Sonoma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202541,500 shares $111,635.00 +75.1%2.6%0.1 $2.69 1/15/202523,700 shares $62,094.00 -36.1%1.8%0.1 $2.62 12/31/202437,100 shares $99,799.00 -45.2%2.8%0.1 $2.69 12/15/202467,700 shares $180,759.00 +67.6%5.1%0.2 $2.67 11/30/202440,400 shares $112,716.00 -47.5%3.1%0.1 $2.79 11/15/202477,000 shares $197,120.00 +40.8%5.8%0.2 $2.56 10/31/202454,700 shares $146,596.00 -31.5%4.1%0.3 $2.68 10/15/202479,900 shares $236,504.00 -25.0%6.1%0.5 $2.96 9/30/2024106,500 shares $326,955.00 +149.4%8.1%0.5 $3.07 9/15/202442,700 shares $149,450.00 -67.2%4.3%0.2 $3.50 Get the Latest News and Ratings for SNOA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024130,300 shares $429,990.00 -65.4%13.0%0.7 $3.30 8/15/2024376,200 shares $88,369.38 -46.0%N/A0.1 $0.23 7/31/2024696,800 shares $254,332.00 +55.5%N/A0.1 $0.37 7/15/2024448,000 shares $174,540.80 -52.7%N/A0.1 $0.39 6/30/2024947,400 shares $201,038.28 +233.7%N/A0.2 $0.21 6/15/2024283,900 shares $50,761.32 -51.6%N/A0.1 $0.18 5/31/2024586,700 shares $120,097.49 +689.6%N/A0.3 $0.20 5/15/202474,300 shares $11,145.00 +59.1%N/A0.1 $0.15 4/30/202446,700 shares $7,420.63 -78.2%N/A0.1 $0.16 4/15/2024214,200 shares $34,571.88 +604.6%N/A0.2 $0.16 3/31/202430,400 shares $5,055.52 -74.2%N/A0 $0.17 3/15/2024117,800 shares $16,173.94 -3.1%N/A0.1 $0.14 2/29/2024121,500 shares $17,860.50 +21.3%N/A0.1 $0.15 2/15/2024100,200 shares $15,621.18 -21.2%N/A0 $0.16 1/31/2024127,200 shares $23,544.72 -81.2%N/A0.1 $0.19 1/15/2024675,100 shares $124,623.46 +238.2%N/A0.4 $0.18 12/31/2023199,600 shares $36,007.84 -48.3%N/A0.2 $0.18 12/15/2023386,000 shares $55,931.40 +348.3%N/A0.4 $0.14 11/30/202386,100 shares $15,222.48 +13.4%N/A0.1 $0.18 11/15/202375,900 shares $12,614.58 +56.2%N/A0.3 $0.17 10/31/202348,600 shares $7,946.10 +17.1%N/A0.3 $0.16 10/15/202341,500 shares $31,955.00 +15.9%N/A1.6 $0.77 9/30/202335,800 shares $27,634.02 -28.1%N/A1.6 $0.77 9/15/202349,800 shares $47,200.44 +16.6%N/A2.1 $0.95 8/31/202342,700 shares $37,255.75 +42.3%N/A0.1 $0.87 8/15/202330,000 shares $27,600.00 -19.8%N/A0.1 $0.92 7/31/202337,400 shares $40,392.00 -29.6%N/A0.1 $1.08 7/15/202353,100 shares $61,065.00 -35.3%N/A0.1 $1.15 6/30/202382,100 shares $87,847.00 -71.5%N/A0.2 $1.07 6/15/2023287,700 shares $376,887.00 +251.7%N/A0.5 $1.31Nvidia’s Next Big Move Comes on Feb. 26 (Ad)Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.Click here to find out who they are. 5/31/202381,800 shares $78,528.00 +7.8%N/A0.1 $0.96 5/15/202375,900 shares $76,218.78 -40.1%N/A0.4 $1.00 4/30/2023126,600 shares $120,054.78 -24.2%N/A0.7 $0.95 4/15/2023167,100 shares $162,087.00 -25.1%N/A0.1 $0.97 3/31/2023223,100 shares $217,812.53 +50.6%N/A0.1 $0.98 3/15/2023148,100 shares $146,663.43 +58.6%N/A0.1 $0.99 2/28/202393,400 shares $113,948.00 -15.0%N/A0.1 $1.22 2/15/2023109,900 shares $168,147.00 -76.5%N/A0.1 $1.53 1/31/2023466,700 shares $774,722.00 +856.4%N/A0.3 $1.66 1/15/202348,800 shares $61,000.00 -4.7%N/A0 $1.25 12/30/202251,200 shares $57,344.00 -46.1%N/A0.1 $1.12 12/15/202295,000 shares $132,050.00 -1.0%N/A0.1 $1.39 11/30/202296,000 shares $164,160.00 -36.6%N/A0.1 $1.71 11/15/2022151,400 shares $337,622.00 +1,974.0%N/A0.2 $2.23 10/31/20227,300 shares $14,527.00 +942.9%N/A0 $1.99 10/15/2022700 shares $1,330.00 -22.2%N/A0 $1.90 9/30/2022900 shares $1,917.00 -84.8%N/A0 $2.13 9/15/20225,900 shares $17,641.00 -19.2%N/A0.1 $2.99 8/31/20227,300 shares $20,294.00 -47.1%N/A0.1 $2.78 8/15/202213,800 shares $45,057.00 -51.9%N/A0.2 $3.27 7/31/202228,700 shares $84,091.00 +36.0%N/A0.2 $2.93 7/15/202221,100 shares $61,190.00 -35.1%N/A0 $2.90 6/30/202232,500 shares $94,900.00 -11.0%N/A0 $2.92 6/15/202236,500 shares $109,500.00 +17.7%N/A0 $3.00 5/31/202231,000 shares $106,950.00 -83.3%N/A0 $3.45 5/15/2022185,500 shares $638,120.00 +138.4%N/A0.2 $3.44 4/30/202277,800 shares $206,948.00 -14.5%N/A0.1 $2.66 4/15/202291,000 shares $290,290.00 +85.0%N/A0.7 $3.19 3/31/202249,200 shares $197,292.00 -3.9%N/A0.3 $4.01 3/15/202251,200 shares $143,360.00 +36.5%N/A1.3 $2.80 2/28/202237,500 shares $119,250.00 -31.6%N/A0.8 $3.18 2/15/202254,800 shares $192,348.00 -34.1%N/A0.9 $3.51 1/31/202283,200 shares $315,328.00 -22.1%N/A0.5 $3.79 1/15/2022106,800 shares $491,280.00 +3.8%N/A0.5 $4.60 12/31/2021102,900 shares $469,224.00 -27.7%N/A0 $4.56 12/15/2021142,300 shares $668,810.00 -19.5%N/A0.1 $4.70 11/30/2021176,800 shares $937,040.00 -28.7%N/A0.1 $5.30 11/15/2021248,000 shares $1.39 million +11.9%N/A0.2 $5.60 10/29/2021221,700 shares $1.29 million -29.9%N/A0.1 $5.80 10/15/2021316,300 shares $1.98 million -61.3%N/A0.1 $6.27 9/30/2021816,800 shares $4.56 million +830.3%N/A0.3 $5.58 9/15/202187,800 shares $462,706.00 +18.7%N/A0 $5.27 8/31/202174,000 shares $469,160.00 -6.2%N/A0 $6.34 8/13/202178,900 shares $455,253.00 -43.3%N/A0 $5.77 7/30/2021139,200 shares $934,032.00 +110.3%N/A1.4 $6.71 7/15/202166,200 shares $421,694.00 +442.6%3.2%0.9 $6.37 6/30/202112,200 shares $89,548.00 +19.6%0.6%0.2 $7.34 6/15/202110,200 shares $80,376.00 -34.2%0.5%0 $7.88 5/28/202115,500 shares $118,420.00 -18.9%0.8%0.1 $7.64 5/14/202119,100 shares $135,992.00 -23.6%0.9%0.1 $7.12Nvidia’s Next Big Move Comes on Feb. 26 (Ad)Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.Click here to find out who they are. 4/30/202125,000 shares $192,500.00 -18.8%1.2%0.1 $7.70 4/15/202130,800 shares $255,948.00 +48.8%1.5%0.1 $8.31 3/31/202120,700 shares $141,795.00 +1,781.8%1.0%0.1 $6.85 3/15/20211,100 shares $8,096.00 -71.8%0.1%0 $7.36 2/26/20213,900 shares $32,409.00 -79.7%0.2%0 $8.31 2/12/202119,200 shares $170,880.00 -9.9%0.9%0 $8.90 1/29/202121,300 shares $189,357.00 -27.3%1.0%0 $8.89 1/15/202129,300 shares $237,330.00 -73.6%1.4%0 $8.10 12/31/2020111,000 shares $805,860.00 -80.9%5.4%0.1 $7.26 12/15/2020582,200 shares $4.84 million +14,828.2%28.3%0.6 $8.31 11/30/20203,900 shares $26,676.00 -44.3%0.2%0.1 $6.84 11/15/20207,000 shares $55,300.00 -17.7%0.4%0.1 $7.90 10/30/20208,500 shares $64,855.00 -48.8%0.4%0.1 $7.63 10/15/202016,600 shares $137,579.14 +8.5%0.8%0 $8.29 9/30/202015,300 shares $127,755.00 -26.1%0.8%0 $8.35 9/15/202020,700 shares $151,058.25 -39.3%1.0%0 $7.30 8/31/202034,100 shares $251,317.00 -7.1%1.7%0.1 $7.37 8/14/202036,700 shares $277,452.00 -93.1%1.8%0 $7.56 7/31/2020532,600 shares $4.89 million +3,089.2%27.5%0.5 $9.18 7/15/202016,700 shares $113,059.00 +9.9%0.9%0 $6.77 6/30/202015,200 shares $113,240.00 +223.4%0.9%0 $7.45 6/15/20204,700 shares $31,208.00 +30.6%0.3%0 $6.64 5/29/20203,600 shares $34,920.00 +414.3%0.2%0 $9.70 5/15/2020700 shares $3,535.00 -46.2%0.0%0 $5.05 4/30/20201,300 shares $6,604.00 -82.4%0.1%0.1 $5.08 4/15/20207,400 shares $38,850.00 -30.8%0.4%0.3 $5.25 3/31/202010,700 shares $51,039.00 +435.0%0.6%0.4 $4.77 3/13/20202,000 shares $10,800.00 +66.7%0.1%0.1 $5.40 2/28/20201,200 shares $7,260.00 +9.1%0.1%0 $6.05 SNOA Short Interest - Frequently Asked Questions What is Sonoma Pharmaceuticals' current short interest? Short interest is the volume of Sonoma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 41,500 shares of SNOA short. 2.61% of Sonoma Pharmaceuticals' shares are currently sold short. Learn More on Sonoma Pharmaceuticals' current short interest. What is a good short interest percentage for Sonoma Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.61% of Sonoma Pharmaceuticals' floating shares are currently sold short. Is Sonoma Pharmaceuticals' short interest increasing or decreasing? Sonoma Pharmaceuticals saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 41,500 shares, an increase of 75.1% from the previous total of 23,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sonoma Pharmaceuticals' float size? Sonoma Pharmaceuticals currently has issued a total of 1,620,000 shares. Some of Sonoma Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sonoma Pharmaceuticals currently has a public float of 1,590,000 shares. How does Sonoma Pharmaceuticals' short interest compare to its competitors? 2.61% of Sonoma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sonoma Pharmaceuticals: GlycoMimetics, Inc. (3.15%), Affimed (5.29%), Spruce Biosciences, Inc. (0.60%), HCW Biologics Inc. (0.42%), Synlogic, Inc. (0.77%), Eagle Pharmaceuticals, Inc. (2.90%), NeuroSense Therapeutics Ltd. (1.13%), ImmunoPrecise Antibodies Ltd. (1.79%), GeoVax Labs, Inc. (5.96%), Minerva Neurosciences, Inc. (0.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Sonoma Pharmaceuticals stock? Short selling SNOA is an investing strategy that aims to generate trading profit from Sonoma Pharmaceuticals as its price is falling. SNOA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sonoma Pharmaceuticals? A short squeeze for Sonoma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNOA, which in turn drives the price of the stock up even further. How often is Sonoma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNOA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies GLYC Short Interest AFMD Short Interest SPRB Short Interest HCWB Short Interest SYBX Short Interest EGRX Short Interest NRSN Short Interest IPA Short Interest GOVX Short Interest NERV Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNOA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
